Literature DB >> 20096751

c-Fos identification of neuroanatomical sites associated with haloperidol and clozapine disruption of maternal behavior in the rat.

C Zhao1, M Li.   

Abstract

Rat maternal behavior is a complex social behavior. Most antipsychotic drugs disrupt active maternal responses (e.g., pup retrieval, pup licking and nest building). Our previous work shows that typical antipsychotic haloperidol disrupts maternal behavior by blocking dopamine D(2) receptors, whereas atypical clozapine works by blocking 5-HT(2A/2C) receptors. The present study used c-Fos immunohistochemistry technique, together with pharmacological tools and behavioral observations, and delineated the neuroanatomical bases of the disruptive effects of haloperidol and clozapine. Postpartum female rats were treated with haloperidol (0.2 mg/kg sc) or clozapine (10.0 mg/kg sc), with or without pretreatment of quinpirole (a selective dopamine D(2)/D(3) agonist, 1.0 mg/kg sc) or 2,5-dimethoxy-4-iodo-amphetamine (DOI, a selective 5-HT(2A/2C) agonist, 2.5 mg/kg sc). They were then sacrificed 2 h later after a maternal behavior test was conducted. Brain regions that have been previously implicated in the regulation of rat maternal behavior and/or in the antipsychotic action were examined. Behaviorally, both haloperidol and clozapine disrupted pup retrieval, pup licking and nest building. Pretreatment of quinpirole, but not DOI, reversed the haloperidol-induced disruptions. In contrast, pretreatment of DOI, but not quinpirole, reversed the clozapine-induced deficits. Neuroanatomically, the nucleus accumbens (both the shell and core), dorsolateral striatum and lateral septum showed increased c-Fos expression to the treatment of haloperidol. In contrast, the nucleus accumbens shell showed increased expression of c-Fos to the treatment of clozapine. More importantly, pretreatment of quinpirole and DOI produced opposite response profiles in the brain regions where haloperidol and clozapine had an effect. Based on these findings, we concluded that haloperidol disrupts active maternal behavior primarily by blocking dopamine D(2) receptors in a neural circuitry involving the nucleus accumbens, dorsolateral striatum and lateral septum. In contrast, clozapine appears to disrupt maternal behavior mainly by blocking serotonin 5-HT(2A/2C) receptors in the nucleus accumbens shell. Copyright 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096751      PMCID: PMC2837940          DOI: 10.1016/j.neuroscience.2010.01.023

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  74 in total

1.  The nucleus accumbens shell is critical for normal expression of pup-retrieval in postpartum female rats.

Authors:  Ming Li; Alison S Fleming
Journal:  Behav Brain Res       Date:  2003-10-17       Impact factor: 3.332

2.  Induction of c-fos-like and fosB-like immunoreactivity reveals forebrain neuronal populations involved differentially in pup-mediated maternal behavior in juvenile and adult rats.

Authors:  M Kalinichev; J S Rosenblatt; Y Nakabeppu; J I Morrell
Journal:  J Comp Neurol       Date:  2000-01-03       Impact factor: 3.215

3.  Clozapine pretreatment modifies haloperidol-elicited forebrain Fos induction: a regionally-specific double dissociation.

Authors:  C D Young; M Bubser; H Y Meltzer; A Y Deutch
Journal:  Psychopharmacology (Berl)       Date:  1999-06       Impact factor: 4.530

4.  The temporal course of expression of c-Fos and Fos B within the medial preoptic area and other brain regions of postpartum female rats during prolonged mother--young interactions.

Authors:  E C Stack; M Numan
Journal:  Behav Neurosci       Date:  2000-06       Impact factor: 1.912

5.  Maternal motivation of lactating rats is disrupted by low dosages of haloperidol.

Authors:  J M Stern; S E Keer
Journal:  Behav Brain Res       Date:  1999-03       Impact factor: 3.332

6.  Modification of haloperidol-induced pattern of c-fos expression by serotonin agonists.

Authors:  P O Tremblay; J Gervais; C Rouillard
Journal:  Eur J Neurosci       Date:  1998-11       Impact factor: 3.386

7.  Maternal behavior of female rats with 6-OHDA lesions in the ventral striatum: characterization of the pup retrieval deficit.

Authors:  S Hansen
Journal:  Physiol Behav       Date:  1994-04

8.  Mesotelencephalic dopamine system and reproductive behavior in the female rat: effects of ventral tegmental 6-hydroxydopamine lesions on maternal and sexual responsiveness.

Authors:  S Hansen; C Harthon; E Wallin; L Löfberg; K Svensson
Journal:  Behav Neurosci       Date:  1991-08       Impact factor: 1.912

9.  Activation of Fos-like immunoreactivity in the medial preoptic area and limbic structures by maternal and social interactions in rats.

Authors:  A S Fleming; E J Suh; M Korsmit; B Rusak
Journal:  Behav Neurosci       Date:  1994-08       Impact factor: 1.912

10.  Growth retardation and altered autonomic control in mice lacking brain serotonin.

Authors:  Natalia Alenina; Dana Kikic; Mihail Todiras; Valentina Mosienko; Fatimunnisa Qadri; Ralph Plehm; Philipp Boyé; Larissa Vilianovitch; Reinhard Sohr; Katja Tenner; Heide Hörtnagl; Michael Bader
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-11       Impact factor: 11.205

View more
  33 in total

1.  Behavioral and pharmacological investigation of anxiety and maternal responsiveness of postpartum female rats in a pup elevated plus maze.

Authors:  Yu Yang; Jingxue Qin; Weihai Chen; Nan Sui; Hong Chen; Ming Li
Journal:  Behav Brain Res       Date:  2015-07-06       Impact factor: 3.332

2.  Serotonin-specific lesions of the dorsal raphe disrupt maternal aggression and caregiving in postpartum rats.

Authors:  M Allie Holschbach; Erika M Vitale; Joseph S Lonstein
Journal:  Behav Brain Res       Date:  2018-04-10       Impact factor: 3.332

3.  Adolescent olanzapine sensitization is correlated with hippocampal stem cell proliferation in a maternal immune activation rat model of schizophrenia.

Authors:  Shinnyi Chou; Sean Jones; Ming Li
Journal:  Brain Res       Date:  2015-06-03       Impact factor: 3.252

4.  Neural basis of the potentiated inhibition of repeated haloperidol and clozapine treatment on the phencyclidine-induced hyperlocomotion.

Authors:  Changjiu Zhao; Tao Sun; Ming Li
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-03-26       Impact factor: 5.067

5.  Clozapine, but not olanzapine, disrupts conditioned avoidance response in rats by antagonizing 5-HT2A/2C receptors.

Authors:  Ming Li; Tao Sun; Alexa Mead
Journal:  J Neural Transm (Vienna)       Date:  2011-10-11       Impact factor: 3.575

Review 6.  The parental brain and behavior: A target for endocrine disruption.

Authors:  Matthieu Keller; Laura N Vandenberg; Thierry D Charlier
Journal:  Front Neuroendocrinol       Date:  2019-05-18       Impact factor: 8.606

7.  Effects of 5-hydroxytryptamine 2C receptor agonist MK212 and 2A receptor antagonist MDL100907 on maternal behavior in postpartum female rats.

Authors:  Weihai Chen; Qi Zhang; Wenxin Su; Haorong Zhang; Yu Yang; Jing Qiao; Nan Sui; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2013-12-07       Impact factor: 3.533

8.  Down-regulation of fatty acid binding protein 7 (Fabp7) is a hallmark of the postpartum brain.

Authors:  Terri M Driessen; Changjiu Zhao; Marissa Saenz; Sharon A Stevenson; Yuji Owada; Stephen C Gammie
Journal:  J Chem Neuroanat       Date:  2018-08-01       Impact factor: 3.052

9.  Behavioral, pharmacological and neuroanatomical analysis of serotonin 2C receptor agonism on maternal behavior in rats.

Authors:  Ruiyong Wu; Jun Gao; Shinnyi Chou; Collin Davis; Ming Li
Journal:  Psychoneuroendocrinology       Date:  2016-08-16       Impact factor: 4.905

10.  HDAC inhibitors restore the capacity of aged mice to respond to haloperidol through modulation of histone acetylation.

Authors:  Janitza L Montalvo-Ortiz; Jack Keegan; Christopher Gallardo; Nicolas Gerst; Kazuhiro Tetsuka; Chris Tucker; Mitsuyuki Matsumoto; Deyu Fang; John G Csernansky; Hongxin Dong
Journal:  Neuropsychopharmacology       Date:  2013-12-24       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.